Related Experiment Video
Updated: Nov 30, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant
Antoney J Ferrey1,2, Ramy Hanna1,2, Uttam G Reddy1,2
1Department of Medicine, Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine Medical Center.
Purpose Of Review:
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the novel virus responsible for the current worldwide pandemic. The scientific and healthcare communities have made every effort to discover and implement treatment options at a historic pace. Patients with kidney disease are uniquely vulnerable to an infectious pandemic because of their need to be in frequent contact with the healthcare system for life-sustaining renal replacement therapy whether it be by dialysis or transplant.
Recent Findings:
The use of targeted viral therapies, extracorporeal therapies, immunosuppressive therapy and public health interventions are important in the management of patients with COVID-19 but require special consideration in patients with kidney disease because of the complexity of their condition.
Summary:
Here, we discuss some of the major efforts made to prevent spread and emerging treatment options for this virus, as they pertain to patients with kidney disease.
Insights
Patients with kidney disease face unique challenges during the SARS-CoV-2 pandemic. This review covers prevention strategies and emerging treatments for COVID-19 in kidney disease patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Virology
Background:
- Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) causes a global pandemic.
- Patients with kidney disease are highly vulnerable due to frequent healthcare system contact for renal replacement therapy.
- Management of COVID-19 in kidney disease patients requires special consideration due to underlying health complexities.
Purpose of the Study:
- To review prevention strategies for SARS-CoV-2 in patients with kidney disease.
- To discuss emerging treatment options for COVID-19 relevant to kidney disease populations.
- To highlight the unique challenges faced by kidney disease patients during the pandemic.
Main Methods:
- Literature review of scientific and healthcare publications.
- Analysis of current treatment modalities and public health interventions.
- Synthesis of information pertaining to kidney disease patient management.
Main Results:
- Targeted viral therapies, extracorporeal therapies, and immunosuppressive treatments are key but need careful application in kidney disease patients.
- Public health interventions are crucial for preventing SARS-CoV-2 spread in this vulnerable group.
- Emerging treatment options require specific adaptation for patients undergoing dialysis or transplantation.
Conclusions:
- Effective management of COVID-19 in kidney disease patients necessitates a multidisciplinary approach.
- Continued research into tailored therapies and preventative measures is essential.
- Protecting kidney disease patients requires a deep understanding of their unique physiological and treatment-related vulnerabilities.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention

